SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-08-17 08:37
Tx date 2021-08-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-1,736 vol
189,614
Filed 2021-08-17 08:35
Tx date 2021-08-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-8,812 vol
319,471
Filed 2021-08-17 08:33
Tx date 2021-08-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-6,153 vol
26,687
Filed 2021-08-17 08:31
Tx date 2021-08-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-6,153 vol
26,687
Filed 2021-08-17 08:27
Tx date 2021-08-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-8,812 vol
130,213
Filed 2021-06-24 12:01
Tx date 2021-06-21
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,350
+3,000 vol
$1.45 each
3,000
Filed 2021-06-24 12:00
Tx date 2020-02-24
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 11:56
Tx date 2021-06-23
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,218
+2,200 vol
$1.46 each
116,986
Filed 2021-06-24 11:53
Tx date 2021-06-22
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,904
+2,700 vol
$1.45 each
114,786
Filed 2021-06-22 15:45
Tx date 2021-06-21
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,871
+2,000 vol
$1.44 each
112,086
Filed 2021-06-12 10:07
Tx date 2021-06-10
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,720
+1,155 vol
$1.49 each
15,145
Filed 2021-06-12 10:06
Tx date 2021-06-10
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$870.00
+600 vol
$1.45 each
13,990
Filed 2021-06-12 10:06
Tx date 2021-06-10
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,620
+3,300 vol
$1.40 each
13,390
Filed 2021-06-12 10:05
Tx date 2021-06-10
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$973.00
+700 vol
$1.39 each
10,090
Filed 2021-05-28 16:09
Tx date 2021-05-28
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+6,000 vol
$1.45 each
62,181
Filed 2021-05-27 10:56
Tx date 2021-05-26
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,771
+1,181 vol
$1.50 each
56,181
Filed 2021-05-21 12:14
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+7,680 vol
7,680
Filed 2021-05-21 12:13
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+7,680 vol
7,680
Filed 2021-05-21 12:12
Tx date 2017-05-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-21 12:10
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+7,680 vol
7,680
Filed 2021-05-21 12:07
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+7,680 vol
7,680
Filed 2021-05-21 12:05
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+7,680 vol
7,680
Filed 2021-05-21 11:59
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights

+23,039 vol
23,039
Filed 2021-05-21 11:39
Tx date 2021-05-17
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 14:43
Tx date 2021-05-20
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,015
+10,000 vol
$1.60 each
55,000
Filed 2021-03-23 11:50
Tx date 2021-03-22
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,849
+4,700 vol
$1.67 each
110,086
Filed 2021-03-23 11:43
Tx date 2020-03-27
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
299,908
Filed 2020-03-27 16:05
Tx date 2020-03-27
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
Filed 2021-03-18 09:32
Tx date 2021-03-16
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,062
+6,500 vol
$1.86 each
105,386
Filed 2021-03-12 16:28
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+7,500 vol
7,500
Filed 2021-03-12 16:27
Tx date 2020-03-16
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:27
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,875 vol
20,625
Filed 2021-03-12 16:25
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+24,000 vol
24,000
Filed 2021-03-12 16:24
Tx date 2020-02-24
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:24
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+7,500 vol
55,000
Filed 2021-03-12 16:22
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+24,000 vol
24,000
Filed 2021-03-12 16:21
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+7,500 vol
191,350
Filed 2021-03-12 16:18
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+24,000 vol
24,000
Filed 2021-03-12 16:17
Tx date 2020-02-24
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:16
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+7,500 vol
101,720
Filed 2021-03-12 16:14
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+24,000 vol
24,000
Filed 2021-03-12 16:13
Tx date 2016-09-12
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:12
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+5,625 vol
98,783
Filed 2021-03-12 16:08
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights

+115,500 vol
115,500
Filed 2021-03-12 16:02
Tx date 2016-04-04
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 15:59
Tx date 2021-03-11
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
329,908
Filed 2016-11-29
Tx date 2016-05-20
$MRV
Metallum Resources Inc.
Armstrong, Philip
4 - Director of Issuer
Holder: 3408256 Canada Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2016-08-13
Tx date 2016-08-10
$MRV
Metallum Resources Inc.
Randall, Robert William George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-30
Tx date 2016-05-30
$MRV
Metallum Resources Inc.
Bullock, Kevin
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-585,000 vol
200,000
Filed 2016-05-16
Tx date 2016-05-16
$MRV
Metallum Resources Inc.
Bullock, Kevin
4 - Director of Issuer
Holder: Elizabeth Pawluch/Leslie Bullock (Control or Direction)
Common Shares
90 - Change in the nature of ownership

-130,000 vol
0